CDEK
← All drugs Report issue

ad5-ncov

Vaccineexperimental

Clinical trial activity

28 trials · 26 clinical orgs · 0 marketing orgs

Phase 1
7
Phase 2
15
Phase 3
6
Phase 4
6

Earliest trial started Mar 16, 2020 (NCT04313127)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2020

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05886790N/AMay 30, 2023People's Liberation Army of China, Xiamen University
NCT05855408Phase 4May 18, 2023Government of China
NCT05517642Phase 3Sep 20, 2022Hospital Ampang, Kuala Lumpur General Hospital, Tianjin Cansino Biotechnology Inc
NCT05373030Phase 4May 14, 2022Government of China
NCT05303584Phase 4Apr 23, 2022Government of China
NCT05169008Phase 3Feb 25, 2022Beijing Institute of Biotechnology, Tianjin Cansino Biotechnology Inc, University of Chile
NCT05204589Phase 3Jan 22, 2022Government of China
NCT05162482Phase 2Jan 1, 2022Aga Khan University, Chughtai Lab, Coalition for Epidemic Preparedness Innovations, Government of Pakistan, Harvard University, International Vaccine Institute, University of Oxford
NCT05124561Phase 3Dec 15, 2021Beijing Institute of Biotechnology, Government of China, Tianjin Cansino Biotechnology Inc
NCT05293223Phase 2Oct 1, 2021Dalhousie University, Fundacion Huesped, Tianjin Cansino Biotechnology Inc
NCT04977024Phase 2Sep 27, 2021City of Hope National Medical Center, National Cancer Institute (NCI)
NCT05043259Phase 1/Phase 2 (Phase 2)Sep 13, 2021Government of China
NCT05012800Phase 4Jul 28, 2021People's Hospital of Hunyuan County, Shanxi Province, People's Liberation Army of China
NCT05005156Phase 2Jun 24, 2021Canadian Center for Vaccinology, Fundacion Huesped, Hospital Fernandez, Tianjin Cansino Biotechnology Inc
NCT04916886N/AJun 3, 2021Government of China, Tianjin Cansino Biotechnology Inc
NCT04889274Phase 1May 10, 2021University of London
NCT04840992Phase 1/Phase 2 (Phase 2)Apr 20, 2021Beijing Institute of Biotechnology, Government of China, Tianjin Cansino Biotechnology Inc
NCT04833101Phase 4Apr 7, 2021Government of China
NCT05019456N/AMar 9, 2021University of Arizona
NCT05313646Phase 4Mar 8, 2021Government of China
Showing 20 of 28 trials
Page 1 / 2

Organizations

Research & Development (26)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Government of ChinaGovernment15852020
Tianjin Cansino Biotechnology IncFor profit13942020
Beijing Institute of BiotechnologyAcademic/Hospital6022020
People's Liberation Army of ChinaGovernment6342020
Canadian Center for VaccinologyAcademic/Hospital3022020
Xiamen UniversityAcademic/Hospital3132020
Fundacion HuespedAcademic/Hospital2212021
Aga Khan UniversityAcademic/Hospital1112022
Chughtai LabAcademic/Hospital1012022
City of Hope National Medical CenterAcademic/Hospital1112021
Coalition for Epidemic Preparedness InnovationsAcademic/Hospital1012022
Dalhousie UniversityAcademic/Hospital1012021
Government of PakistanGovernment1012022
Harvard UniversityAcademic/Hospital1012022
Hospital AmpangAcademic/Hospital1012022
Hospital FernandezAcademic/Hospital1012021
Huazhong University of Science and TechnologyAcademic/Hospital1012020
International Vaccine InstituteAcademic/Hospital1012022
Kuala Lumpur General HospitalAcademic/Hospital1012022
National Cancer Institute (NCI)Government1012021
26 organizations
Page 1 / 2